Mechanism of Action
GPRC6A Receptor Signaling
Undercarboxylated osteocalcin (ucOC) binds GPRC6A, a Class C GPCR expressed on pancreatic beta cells, skeletal muscle, brain neurons, and Leydig cells. GPRC6A coupling through Gs increases cAMP, activating PKA and downstream targets. In beta cells, this stimulates insulin and GLP-1 secretion. In muscle, GPRC6A activation promotes fatty acid oxidation and glucose uptake. The carboxylation state of osteocalcin determines activity: ucOC is active at GPRC6A, while fully carboxylated OC (cOC) has reduced receptor affinity.
Metabolic Effects
Osteocalcin improves insulin sensitivity through multiple mechanisms: direct stimulation of insulin secretion (beta cell), enhanced skeletal muscle glucose uptake via AMPK activation and GLUT4 upregulation, and promotion of muscle fatty acid oxidation (upregulating MCK, CPT-1, and PGC-1alpha). Osteocalcin-deficient mice develop insulin resistance, obesity, and type 2 diabetes, phenotypes reversed by osteocalcin injection. These observations established bone as an endocrine organ.
Brain and Testosterone Effects
In the brain, GPRC6A on hippocampal and cortical neurons mediates osteocalcin effects on neurotransmitter synthesis, synaptic plasticity, and memory consolidation. Osteocalcin injections improve spatial and associative memory in aging mice. In Leydig cells of the testes, GPRC6A activation stimulates testosterone synthesis (upregulating StAR and CYP11A1). Osteocalcin may represent the mechanism by which exercise increases testosterone and improves cognition, both effects blocked by GPRC6A deletion.
Research Summary
Metabolic and Cognitive Aging
TranslationalHuman plasma osteocalcin declines ~25-50% between ages 30-70. Low osteocalcin correlates with higher BMI, worse insulin sensitivity, lower testosterone, and poorer cognitive performance in cross-sectional studies. Exercise interventions (particularly resistance and high-intensity training) acutely and chronically increase osteocalcin. Recombinant osteocalcin injection in elderly mice restores muscle exercise capacity, glucose tolerance, and memory to youthful levels.
Exercise Performance
TranslationalA 2019 Cell paper demonstrated that during exercise, bone-derived osteocalcin acts on muscle to increase glucose and fatty acid utilization, supporting sustained effort. Osteocalcin-deficient mice show markedly impaired exercise endurance. Osteocalcin injections enhance running performance in sedentary old mice. Human exercise studies show blood osteocalcin rises within 10 minutes of exercise onset, preceding other known exercise hormones.
Memory and Hippocampal Function
Preclinical/TranslationalOsteocalcin crosses the blood-brain barrier and activates hippocampal neurons via GPRC6A. In mouse models of aging, osteocalcin infusion restores hippocampal acetylcholine synthesis, enhances long-term potentiation, and improves performance on novel object recognition and contextual fear conditioning. Epidemiological data shows positive correlation between serum osteocalcin and cognitive performance scores in older adults.
Calculate your Osteocalcin dose Vial strength, BAC water, exact syringe draw in IU. Free, no signup. Open Calc →
Research Protocols
| Goal | Dose | Frequency | Route |
|---|---|---|---|
| Metabolic improvement (aged mice) | 30 ng/g SC | Daily for 2-8 weeks | SC injection |
| Exercise performance study | 60 ng/g SC | Single pre-exercise dose | SC |
| Biomarker (clinical) | Blood draw (ELISA) | Fasting morning sample | Serum |
Human clinical dosing not established. Preclinical doses in mice are high relative to body weight. Bioavailability of exogenous ucOC in humans under study. Vitamin K status affects endogenous carboxylation ratio.
Interactions
Safety Profile
Osteocalcin has a favorable safety profile in animal studies even at pharmacological doses. No significant adverse effects beyond expected metabolic improvements (lower blood glucose, reduced body fat) have been reported. In humans, high serum osteocalcin (as a biomarker) is associated with better health outcomes, suggesting excess is not harmful. Theoretical concerns include potential over-suppression of appetite or excessive testosterone stimulation at very high doses, but neither has been observed at tested preclinical doses. Human pharmacokinetic and safety studies are ongoing.
References
- [1]Lee NK, et al. Endocrine regulation of energy metabolism by the skeleton. Cell. 2007;130:456-469.
- [2]Mera P, et al. Osteocalcin signaling in myofibers is necessary for acute exercise adaptation. Cell Metab. 2016.
- [3]Khrimian L, et al. Gpr158 mediates osteocalcin hippocampal memory effects. J Exp Med. 2017.